DO WE NEED TO EXTEND CMV PROPHYLAXIS COURSE IN HIGH RISK PATIENTS POST TRANSPLANT? A SINGLE CENTRE RETROSPECTIVE STUDY OF CMV INFECTION IN KIDNEY TRANSPLANT PATIENTS

被引：0
|
作者：
Aswad, Mayar Ghazal [1 ]
Smith, Christopher [1 ]
Khan, Shakeeb [1 ]
Page, Amy [1 ]
Black, John [1 ]
Chughtai, Shafiq [1 ]
Dharmayan, Stalin [1 ]
Ali, Ahmed [1 ]
Rajagopal, Poyyamozhi [1 ]
Doughman, Tahir [1 ]
Malik, Shafi [1 ]
Bagul, Atul [1 ]
机构：
[1] Univ Hosp Leicester, Leicester, Leics, England
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P379
引用
收藏
页码：491 / 491
页数：1
相关论文
共 50 条
  • [21] Utilization of a CMV T Cell Immunity Panel in Directing Duration of Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients
    Ray, A.
    Garner, B.
    Klein, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S793 - S793
  • [22] Evaluation of Two Different CMV-Immunoglobulin Regimens for Combined CMV Prophylaxis in High-Risk Patients following Lung Transplant
    Mora, Victor M.
    Ussetti, Piedad
    de Pablo, Alicia
    Iturbe, David
    Laporta, Rosalia
    Alonso, Rodrigo
    Aguilar, Myriam
    Quezada, Carlos A.
    Cifrian, Jose M.
    MICROORGANISMS, 2023, 11 (01)
  • [23] CMV prophylaxis in high-risk renal transplant patients (D+/R-) by acyclovir with or without hyperimmune (CMV) immunoglobulins: A prospective study
    Rostaing, L
    Martinet, O
    Cisterne, JM
    Icart, J
    Chabannier, MH
    Durand, D
    AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (06) : 489 - 494
  • [24] Frequency of cytomegalovirus (CMV) in post renal transplant patients: A single center experience
    Munib, Syed
    Malik, Asif
    RAWAL MEDICAL JOURNAL, 2018, 43 (02): : 224 - 226
  • [25] CMV-Specific Cell-Mediated Immunity after Valgancyclovir Prophylaxis Predicts Late Onset CMV Infection in Kidney Transplant Patients.
    Jarque, M.
    Crespo, E.
    Melilli, E.
    Manonelles, A.
    Montero, N.
    Luque, S.
    Cruzado, J.
    Grinyo, J.
    Bestard, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 318 - 318
  • [26] Do We Really Need CMV Prophylaxis in Every Aviremic High Risk CMV-Seropositive Liver Transplant Recipients (D1/R1) in Pakistani Population
    Dogar, Abdul Wahab
    Hussain, Azhar
    Ullah, Kaleem
    Ud-Din, Shams
    Khan, Abdul Basit
    Ghaffar, Abdul
    Hurairah, Abu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1207 - S1207
  • [27] Protection from Cancer in Kidney Transplant Patients by γδ T Cells: Role of CMV Infection?
    Soderberg-Naucler, Cecilia
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (01): : 11 - 13
  • [28] Risk Factors of Post-Transplant High-Grade CMV Reactivation in CMV-Seropositive Patients in the Modern Immunosuppressive Era
    Saito, M.
    Satoh, S.
    Numakura, K.
    Inoue, T.
    Tsuruta, H.
    Akihama, S.
    Tsuchiya, N.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 188 - 188
  • [29] Comparison of Different Prophylactic Therapies for CMV Infection in High Risk Kidney and Kidney/Pancreas Transplant Recipients
    Raza, S. M.
    Balla, A.
    Bastnagel, W.
    Duhart, B. T., Jr.
    Krauss, A. G.
    Eason, J. D.
    Mya, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 143 - 143
  • [30] Characterization of Cytomegalovirus (CMV) Viremia and Disease in CMV High-Risk Kidney Transplant Recipients: A Single-Center Experience
    Padmanabhan, Shanmugha Vigneshwar
    Pavlakis, Martha
    Blair, Barbra M.
    Chopra, Bhavna
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345